South Korea to Use Affymetrix Arrays in Large Genome-Wide Association Study | GenomeWeb
NEW YORK (GenomeWeb News) — The South Korean government will use Affymetrix’s microarray technology in a large human genome-wide association study to identify genetic causes of “lifestyle-related” complex diseases that are prevalent in the country, the firm said today.
 
The Korean Association Resource project, also known as KARE, is commissioned by Korea’s National Institute of Health and its Center for Disease Control and Prevention, Affy said.
 

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

Biomedical research projects are generating a ton of data that still needs to be analyzed, NPR reports.

Theranos is retiring some of its board members, including Henry Kissinger and George Shultz, Business Insider reports.

The heads of 29 scientific societies and some 2,300 researchers call on President-elect Donald Trump to rely on and support science in two separate letters.

In Science this week: genetically modified flu virus could be key to new live vaccines, and more.